Shenzhen Hannuo Medical Technology

Shenzhen, China Founded: 2018 • Age: 8 yrs
Extracorporeal circulation products including ECMO are developed for medical support.

About Shenzhen Hannuo Medical Technology

Shenzhen Hannuo Medical Technology is a company based in Shenzhen (China) founded in 2018.. Shenzhen Hannuo Medical Technology has raised $14.04 million across 2 funding rounds from investors including China Developement Bank, China Vision Capital and Guangdong Hengjian Investment Holdings. Shenzhen Hannuo Medical Technology operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Spectrumedics, among others.

  • Headquarter Shenzhen, China
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14.04 M (USD)

    in 2 rounds

  • Latest Funding Round
    $14.04 M (USD), Series E

    Jan 05, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Shenzhen Hannuo Medical Technology

Shenzhen Hannuo Medical Technology has successfully raised a total of $14.04M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $14.04 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series E — $14.0M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Series E - Shenzhen Hannuo Medical Technology Valuation

investors

Jun, 2023 Amount Series D - Shenzhen Hannuo Medical Technology Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Shenzhen Hannuo Medical Technology

Shenzhen Hannuo Medical Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include China Developement Bank, China Vision Capital and Guangdong Hengjian Investment Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
China Vision Capital manages diversified investment portfolios across various asset classes.
Founded Year Domain Location
Development finance offered via long-term lending and bond issuance.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Shenzhen Hannuo Medical Technology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Shenzhen Hannuo Medical Technology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Shenzhen Hannuo Medical Technology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Shenzhen Hannuo Medical Technology

Shenzhen Hannuo Medical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Spectrumedics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medical devices for hypertension and atherosclerosis treatment are developed.
domain founded_year HQ Location
Cardiovascular products and equipment are developed, manufactured, and distributed.
domain founded_year HQ Location
Developer of medical device for the treatment of peripheral thrombectomy
domain founded_year HQ Location
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
domain founded_year HQ Location
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
domain founded_year HQ Location
Cardiovascular medical devices are developed and manufactured in China.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Shenzhen Hannuo Medical Technology

Frequently Asked Questions about Shenzhen Hannuo Medical Technology

When was Shenzhen Hannuo Medical Technology founded?

Shenzhen Hannuo Medical Technology was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Shenzhen Hannuo Medical Technology located?

Shenzhen Hannuo Medical Technology is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Is Shenzhen Hannuo Medical Technology a funded company?

Shenzhen Hannuo Medical Technology is a funded company, having raised a total of $14.04M across 2 funding rounds to date.

What does Shenzhen Hannuo Medical Technology do?

Founded in 2018 in Shenzhen, China, extracorporeal circulation products are developed by Shenzhen Hannuo Medical Technology. Focus is placed on extracorporeal membrane oxygenation (ECMO) technology, which supports cardiovascular and cerebrovascular functions as well as organ protection. Operations center on medical device innovation within the healthcare sector, with products aimed at clinical applications for patient care and recovery.

Who are the top competitors of Shenzhen Hannuo Medical Technology?

Shenzhen Hannuo Medical Technology's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.

Who are Shenzhen Hannuo Medical Technology's investors?

Shenzhen Hannuo Medical Technology has 3 investors. Key investors include China Developement Bank, China Vision Capital, and Guangdong Hengjian Investment Holdings.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available